ML385

644 Cited Publications
Revisión del cliente

Based on 644 publication(s) in Google Scholar

ML385 is a potent and selective Nrf2 inhibitor with an IC50 of 1.9 μM. ML385 directly binds to the Neh1 domain of NRF2, interferes with the binding of the MAFG-NRF2 protein complex to the antioxidant response element (ARE) DNA sequence, thereby blocking the expression of downstream target genes of NRF2. ML385 can be used in studies related to adult T-cell leukemia, breast cancer, myocardial ischemia/reperfusion injury, non-small cell lung cancer, esophageal squamous cell carcinoma, head and neck squamous cell carcinoma, and lung squamous cell carcinoma.

Para uso exclusivo en investigación. No vendemos a pacientes.

  • Pureza: 99.84%
  • No. CAS: 846557-71-9
  • Fòrmula: C29H25N3O4S
  • Peso molecular:511.59
  • Almacenamiento:
    Powder   -20°C, 3 years , 4°C, 2 years ; In solvent   -80°C, 2 years , -20°C, 1 year
  • Actividad biológica
  • Chemical Information
  • Solvente y solubilidad
  • Pureza y Documentación
  • Referencias
  • Help & FAQs

Publications Citing Use of MedChemExpress (MCE) ML385

More
Customer Validation & Images
WBIHCIFRT-PCR
  • RT-PCR
  • WB
  • WB
  • IF
  • RT-PCR
  • WB
  • WB
  • WB
  • IHC
  • WB
  • WB
  • WB

Ver todos los productos específicos de isoformas mTOR

More
MOQ
Minimum order quantity
100 mg

Obtener un presupuesto En stock

Other size
Obtener un presupuesto
Please select quantity
Amount: USD 0.00